[RNAZ] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[RNAZ] TransCode Therapeutics, Inc.
Announcement Date
14-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 55.29%
YoY- 56.21%
Quarter Report
RNAZ's Result
RNAZ's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 0 0 0 0 0 -
PBT -2,321 -5,300 -4,290 -2,330 -1,374 13.99%
Tax 0 27 655 -30 854 -
NP -2,321 -5,300 -4,290 -2,300 -1,374 13.99%
Tax Rate - - - - - -
Total Cost 2,321 5,300 4,290 2,300 1,374 13.99%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -0.16 -67.95 -264.45 -164.25 -172.19 -82.51%
EPS Diluted -0.16 -67.15 -264.45 -159.60 -172.19 -82.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.